Mesoblast Limited (MESO)

Healthcare · Biotechnology · NASDAQ

Mesoblast Limited (MESO) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $2.07B and a free-cash-flow yield of -2.6%. Over the most recent reported fiscal year, revenue grew 191.4%.

Market cap	$2.07B
Trailing P/E	—
FCF yield	-2.6%
Revenue growth (YoY)	+191.4%
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live MESO data on Nama Insights →